Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 101 - 125 of 5886 in total
Quercus agrifolia pollen is the pollen of the Quercus agrifolia plant. Quercus agrifolia pollen is mainly used in allergenic testing.
Approved
Matched Synonyms: … coast live oak pollen extract …
Matched Products: … California Live Oak ... Coast Live Oak Pollen ... California (Coastal) Live Oak …
Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While...
Approved
Investigational
Matched Synonyms: … AMPH-b ... Amfotericina B ... Amphotericin B
Matched Name: … Amphotericin B
Matched Description: … Amphotericin B shows a high order of in vitro activity against many species of fungi. ... Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. ... While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be …
Matched Salts name: … Amphotericin B Cholesteryl Sulfate Complex …
Matched Categories: … amphotericin B ... amphotericin B ... amphotericin B ... amphotericin B
Matched Products: … Amphotericin B ... AMPHO-B ... PHOSOME B ANFOTERICINA B LIPOSOMAL PARA INYECCIÓN 50 MG …
Clostridium tetani toxoid antigen (formaldehyde inactivated) is a vaccine for intramuscular injection. It is used for active immunization of children 7 years of age or older, and adults, for prevention of tetanus. The toxoid in the Clostridium tetani culture is grown and detoxified followed by purification via ammonium sulfate filtration...
Approved
Matched Name: … Clostridium tetani toxoid antigen (formaldehyde inactivated) …
Matched Description: … Clostridium tetani toxoid antigen (formaldehyde inactivated) is a vaccine for intramuscular injection …
Matched Mixtures name: … ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN ... CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN ... PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN …
Neisseria meningitidis serogroup B recombinant lp2086 a05 protein variant antigen is a sterile vaccine for intramuscular injection indicated for the active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. It is contained in the suspension of Trumenba, which is a vaccine is composed of two recombinant lipidated...
Approved
Matched Name: … Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen
Matched Description: … Neisseria meningitidis serogroup B recombinant lp2086 a05 protein variant antigen is a sterile vaccine ... one from fHBP subfamily A and one from subfamily B (A05 and B01, respectively). ... for the active immunization to prevent invasive disease caused by *Neisseria meningitidis* serogroup B. …
Approved
Investigational
Matched Name: … Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) …
Matched Mixtures name: … ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN ... CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN ... PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN …
Recombinant stabilized RSV B prefusion F antigen is one component of a bivalent respiratory syncytial virus (RSV) vaccine called Abrysvo. The vaccine comprises two antigens - the other being recombinant stabilized RSV A prefusion F antigen - which have been expressed in Chinese hamster ovary cell lines and then purified...
Approved
Matched Name: … Recombinant stabilized RSV A prefusion F antigen
Matched Description: … Recombinant stabilized RSV B prefusion F antigen is one component of a bivalent respiratory syncytial ... virus (RSV) vaccine called Abrysvo. ... The vaccine comprises two antigens - the other being [recombinant stabilized RSV A prefusion F antigen
Matched Categories: … Respiratory syncytial virus (RSV) vaccines …
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) is a vaccine that contains inactivated acellular pertussis antigen that is isolated from Bordetella pertussis culture.
Approved
Investigational
Matched Name: … Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) …
Matched Description: … inactivated acellular pertussis antigen that is isolated from Bordetella pertussis culture. ... Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) is a vaccine that contains …
Matched Mixtures name: … ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN ... CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN ... (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA …
Meningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup C. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup C.
Approved
Experimental
Investigational
Matched Synonyms: … Neisseria meningitidis group C (strain C11) oligosaccharide CRM-197 adipic acid conjugate ... Meningococcal polysaccharide antigen group C ... Neisseria meningitidis group C capsular polysaccharide antigen
Streptococcus pneumoniae type 6b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 6b of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 6b capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 6b capsular polysaccharide antigen is a vaccine that contains highly purified …
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) is a vaccine that is used in the prophylaxis of Pertussis (whooping cough), which is caused by a small Gram-negative coccobacillus that infects the mucosal layers of the human respiratory tract.
Approved
Matched Name: … Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) …
Matched Description: … Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) is a vaccine that is used …
Streptococcus pneumoniae type 2 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 2 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 2 capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 2 capsular polysaccharide antigen is a vaccine that contains highly purified …
Streptococcus pneumoniae type 7f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 7f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 7f capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 7f capsular polysaccharide antigen is a vaccine that contains highly purified …
Streptococcus pneumoniae type 9v capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 9v of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 9v capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 9v capsular polysaccharide antigen is a vaccine that contains highly purified …
Streptococcus pneumoniae type 20 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 20 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 20 capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 20 capsular polysaccharide antigen is a vaccine that contains highly purified …
Streptococcus pneumoniae type 10a capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 10a of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 10a capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 10a capsular polysaccharide antigen is a vaccine that contains highly purified …
Streptococcus pneumoniae type 33f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 33f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 33f capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 33f capsular polysaccharide antigen is a vaccine that contains highly purified …
Human papillomavirus type 33 L1 capsid protein antigen is contained in Gardasil is a vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) type 33. The vaccine is prepared from the purified...
Approved
Matched Name: … Human papillomavirus type 33 L1 capsid protein antigen
Matched Description: … Human papillomavirus type 33 L1 capsid protein antigen is contained in Gardasil is a vaccine for intramuscular ... The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein …
Matched Mixtures name: … GARDASIL® 9 VACUNA RECOMBINANTE NONAVALENTE CONTRA EL VIRUS DEL PAPILOMA HUMANO …
Human papillomavirus type 6 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus...
Approved
Investigational
Matched Name: … Human papillomavirus type 6 L1 capsid protein antigen
Matched Description: … Human papillomavirus type 6 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human ... The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein …
Matched Mixtures name: … GARDASIL® 9 VACUNA RECOMBINANTE NONAVALENTE CONTRA EL VIRUS DEL PAPILOMA HUMANO …
Human papillomavirus type 16 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus...
Approved
Investigational
Matched Name: … Human papillomavirus type 16 L1 capsid protein antigen
Matched Description: … Human papillomavirus type 16 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human ... The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein …
Matched Mixtures name: … GARDASIL® 9 VACUNA RECOMBINANTE NONAVALENTE CONTRA EL VIRUS DEL PAPILOMA HUMANO …
VidPrevtyn Beta is an adjuvanted, recombinant COVID-19 vaccine developed collaboratively by GlaxoSmithKline (GSK) and Sanofi Pasteur. It comprises a recombinant SARS-CoV-2 spike protein (B.1.351 strain) - produced by recombinant DNA technology using a baculovirus expression system in an insect cell line that is derived from Sf9 cells of the fall...
Approved
Investigational
Matched Synonyms: … SARS-CoV-2 prefusion Spike delta TM protein, recombinant (B.1.351 strain) …
Matched Description: … [L49691] It comprises a recombinant SARS-CoV-2 spike protein (B.1.351 strain) - produced by recombinant …
Equine Botulinum Neurotoxin B Immune FAB2 is composed of a mixture of immune globulin fragments purified from plasma of horses that were previously immunized with botulinum toxin serotype B. It is intravenously administered for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes B in...
Approved
Experimental
Investigational
Matched Synonyms: … Botulinum Neurotoxin B immune FAB2 (equine) ... BOTULINUM NEUROTOXIN B IMMUNE FAB2, EQUINE …
Matched Name: … Equine Botulinum Neurotoxin B Immune FAB2 …
Matched Description: … from plasma of horses that were previously immunized with botulinum toxin serotype B. ... Equine Botulinum Neurotoxin B Immune FAB2 is composed of a mixture of immune globulin fragments purified ... of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes B
Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup a. The vaccine contains N. meningitis serogroup a capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are...
Approved
Investigational
Matched Name: … Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen
Matched Description: … Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active …
Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine contains* N. meningitis* serogroup y capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are...
Approved
Matched Name: … Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen
Matched Description: … Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen is an active …
Streptococcus pneumoniae type 11A capsular polysaccharide diphtheria CRM197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 11A individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides...
Approved
Matched Name: … Streptococcus pneumoniae type 11A capsular polysaccharide diphtheria CRM197 protein conjugate antigen
Matched Description: … Streptococcus pneumoniae type 11A capsular polysaccharide diphtheria CRM197 protein conjugate antigen ... protein, a nontoxic variant of diphtheria toxin isolated from cultures of *Corynebacterium diphtheriae* strain
Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup W-135. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup W-135.
Approved
Experimental
Investigational
Matched Synonyms: … Meningococcal polysaccharide antigen group W-135 ... Neisseria meningitidis group W-135 polysaccharide antigen, A ... neisseria meningitidis group W-135 capsular polysaccharide antigen
Displaying drugs 101 - 125 of 5886 in total